Selected research
Market Structure
Global Plasma Volume Expanders (PVEs) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Plasma Volume Expanders (PVEs) market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Plasma Volume Expanders (PVEs) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Plasma Volume Expanders (PVEs) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Plasma Volume Expanders (PVEs) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Plasma Volume Expanders (PVEs) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Plasma Volume Expanders (PVEs) include Abbott, Pfizer, Takeda Pharmaceuticals USA, Inc, Rusoma Laboratories Pvt, Pharmacosmos, PHARMACIA (CANADA) INC, Kedrion Biopharma, IBM Micromedex and Grifols, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Plasma Volume Expanders (PVEs) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Plasma Volume Expanders (PVEs) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Plasma Volume Expanders (PVEs) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Plasma Volume Expanders (PVEs) market size, projected growth trends, production technologies, key applications, and end-use industries.
Plasma Volume Expanders (PVEs) Segment by Company
Abbott
Pfizer
Takeda Pharmaceuticals USA, Inc
Rusoma Laboratories Pvt
Pharmacosmos
PHARMACIA (CANADA) INC
Kedrion Biopharma
IBM Micromedex
Grifols
Fresenius Kabi
CSL Behring
Bio Products Laboratory Limited(Albuminex)
B. Braun Medical, Inc
Plasma Volume Expanders (PVEs) Segment by Type
Hydroxyethyl Starch (Hetastarch/HES)
Dextran
Polyvinyl Pyrrolidone
Degraded Gelatin Polymer (Polygeline)
Albumin
Others
Plasma Volume Expanders (PVEs) Segment by Application
Shock
Dehydration
Hypernatremia
Hypoglycemia
Hemorrhage
Sepsis
Plasma Volume Expanders (PVEs) Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Plasma Volume Expanders (PVEs) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Plasma Volume Expanders (PVEs) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Plasma Volume Expanders (PVEs).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Plasma Volume Expanders (PVEs) market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Plasma Volume Expanders (PVEs) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Plasma Volume Expanders (PVEs) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Plasma Volume Expanders (PVEs) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Hydroxyethyl Starch (Hetastarch/HES)
- Dextran
- Polyvinyl Pyrrolidone
- Degraded Gelatin Polymer (Polygeline)
- Albumin
- Others
Applications
- Shock
- Dehydration
- Hypernatremia
- Hypoglycemia
- Hemorrhage
- Sepsis
Companies covered
- Abbott
- Pfizer
- Takeda Pharmaceuticals USA, Inc
- Rusoma Laboratories Pvt
- Pharmacosmos
- PHARMACIA (CANADA) INC
- Kedrion Biopharma
- IBM Micromedex
- Grifols
- Fresenius Kabi
- CSL Behring
- Bio Products Laboratory Limited(Albuminex)
- B. Braun Medical, Inc
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Plasma Volume Expanders (PVEs) Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Plasma Volume Expanders (PVEs) Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Plasma Volume Expanders (PVEs) Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Plasma Volume Expanders (PVEs) Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Plasma Volume Expanders (PVEs) Market Dynamics
- 2.1 Plasma Volume Expanders (PVEs) Industry Trends
- 2.2 Plasma Volume Expanders (PVEs) Industry Drivers
- 2.3 Plasma Volume Expanders (PVEs) Industry Opportunities and Challenges
- 2.4 Plasma Volume Expanders (PVEs) Industry Restraints
3 Plasma Volume Expanders (PVEs) Market by Manufacturers
- 3.1 Global Plasma Volume Expanders (PVEs) Revenue by Manufacturers (2021-2026)
- 3.2 Global Plasma Volume Expanders (PVEs) Sales by Manufacturers (2021-2026)
- 3.3 Global Plasma Volume Expanders (PVEs) Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Plasma Volume Expanders (PVEs) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Plasma Volume Expanders (PVEs) Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Plasma Volume Expanders (PVEs) Manufacturers, Product Type & Application
- 3.7 Global Plasma Volume Expanders (PVEs) Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Plasma Volume Expanders (PVEs) Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Plasma Volume Expanders (PVEs) Players Market Share by Revenue in 2025
- 3.8.3 2025 Plasma Volume Expanders (PVEs) Tier 1, Tier 2, and Tier 3
4 Plasma Volume Expanders (PVEs) Market by Type
- 4.1 Plasma Volume Expanders (PVEs) Type Introduction
- 4.1.1 Hydroxyethyl Starch (Hetastarch/HES)
- 4.1.2 Dextran
- 4.1.3 Polyvinyl Pyrrolidone
- 4.1.4 Degraded Gelatin Polymer (Polygeline)
- 4.1.5 Albumin
- 4.1.6 Others
- 4.2 Global Plasma Volume Expanders (PVEs) Sales by Type
- 4.2.1 Global Plasma Volume Expanders (PVEs) Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Plasma Volume Expanders (PVEs) Sales by Type (2021-2032)
- 4.2.3 Global Plasma Volume Expanders (PVEs) Sales Market Share by Type (2021-2032)
- 4.3 Global Plasma Volume Expanders (PVEs) Revenue by Type
- 4.3.1 Global Plasma Volume Expanders (PVEs) Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Plasma Volume Expanders (PVEs) Revenue by Type (2021-2032)
- 4.3.3 Global Plasma Volume Expanders (PVEs) Revenue Market Share by Type (2021-2032)
5 Plasma Volume Expanders (PVEs) Market by Application
- 5.1 Plasma Volume Expanders (PVEs) Application Introduction
- 5.1.1 Shock
- 5.1.2 Dehydration
- 5.1.3 Hypernatremia
- 5.1.4 Hypoglycemia
- 5.1.5 Hemorrhage
- 5.1.6 Sepsis
- 5.2 Global Plasma Volume Expanders (PVEs) Sales by Application
- 5.2.1 Global Plasma Volume Expanders (PVEs) Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Plasma Volume Expanders (PVEs) Sales by Application (2021-2032)
- 5.2.3 Global Plasma Volume Expanders (PVEs) Sales Market Share by Application (2021-2032)
- 5.3 Global Plasma Volume Expanders (PVEs) Revenue by Application
- 5.3.1 Global Plasma Volume Expanders (PVEs) Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Plasma Volume Expanders (PVEs) Revenue by Application (2021-2032)
- 5.3.3 Global Plasma Volume Expanders (PVEs) Revenue Market Share by Application (2021-2032)
6 Global Plasma Volume Expanders (PVEs) Sales by Region
- 6.1 Global Plasma Volume Expanders (PVEs) Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Plasma Volume Expanders (PVEs) Sales by Region (2021-2032)
- 6.2.1 Global Plasma Volume Expanders (PVEs) Sales by Region (2021-2026)
- 6.2.2 Global Plasma Volume Expanders (PVEs) Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Plasma Volume Expanders (PVEs) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Plasma Volume Expanders (PVEs) Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Plasma Volume Expanders (PVEs) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Plasma Volume Expanders (PVEs) Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Plasma Volume Expanders (PVEs) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Plasma Volume Expanders (PVEs) Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Plasma Volume Expanders (PVEs) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Plasma Volume Expanders (PVEs) Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Plasma Volume Expanders (PVEs) Revenue by Region
- 7.1 Global Plasma Volume Expanders (PVEs) Revenue by Region
- 7.1.1 Global Plasma Volume Expanders (PVEs) Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Plasma Volume Expanders (PVEs) Revenue by Region (2021-2026)
- 7.1.3 Global Plasma Volume Expanders (PVEs) Revenue by Region (2027-2032)
- 7.1.4 Global Plasma Volume Expanders (PVEs) Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Plasma Volume Expanders (PVEs) Revenue (2021-2032)
- 7.2.2 North America Plasma Volume Expanders (PVEs) Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Plasma Volume Expanders (PVEs) Revenue (2021-2032)
- 7.3.2 Europe Plasma Volume Expanders (PVEs) Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Plasma Volume Expanders (PVEs) Revenue (2021-2032)
- 7.4.2 Asia-Pacific Plasma Volume Expanders (PVEs) Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Plasma Volume Expanders (PVEs) Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Plasma Volume Expanders (PVEs) Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Abbott
- 8.1.1 Abbott Company Information
- 8.1.2 Abbott Business Overview
- 8.1.3 Abbott Plasma Volume Expanders (PVEs) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Abbott Plasma Volume Expanders (PVEs) Product Portfolio
- 8.1.5 Abbott Recent Developments
- 8.2 Pfizer
- 8.2.1 Pfizer Company Information
- 8.2.2 Pfizer Business Overview
- 8.2.3 Pfizer Plasma Volume Expanders (PVEs) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Pfizer Plasma Volume Expanders (PVEs) Product Portfolio
- 8.2.5 Pfizer Recent Developments
- 8.3 Takeda Pharmaceuticals USA, Inc
- 8.3.1 Takeda Pharmaceuticals USA, Inc Company Information
- 8.3.2 Takeda Pharmaceuticals USA, Inc Business Overview
- 8.3.3 Takeda Pharmaceuticals USA, Inc Plasma Volume Expanders (PVEs) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Takeda Pharmaceuticals USA, Inc Plasma Volume Expanders (PVEs) Product Portfolio
- 8.3.5 Takeda Pharmaceuticals USA, Inc Recent Developments
- 8.4 Rusoma Laboratories Pvt
- 8.4.1 Rusoma Laboratories Pvt Company Information
- 8.4.2 Rusoma Laboratories Pvt Business Overview
- 8.4.3 Rusoma Laboratories Pvt Plasma Volume Expanders (PVEs) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Rusoma Laboratories Pvt Plasma Volume Expanders (PVEs) Product Portfolio
- 8.4.5 Rusoma Laboratories Pvt Recent Developments
- 8.5 Pharmacosmos
- 8.5.1 Pharmacosmos Company Information
- 8.5.2 Pharmacosmos Business Overview
- 8.5.3 Pharmacosmos Plasma Volume Expanders (PVEs) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Pharmacosmos Plasma Volume Expanders (PVEs) Product Portfolio
- 8.5.5 Pharmacosmos Recent Developments
- 8.6 PHARMACIA (CANADA) INC
- 8.6.1 PHARMACIA (CANADA) INC Company Information
- 8.6.2 PHARMACIA (CANADA) INC Business Overview
- 8.6.3 PHARMACIA (CANADA) INC Plasma Volume Expanders (PVEs) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 PHARMACIA (CANADA) INC Plasma Volume Expanders (PVEs) Product Portfolio
- 8.6.5 PHARMACIA (CANADA) INC Recent Developments
- 8.7 Kedrion Biopharma
- 8.7.1 Kedrion Biopharma Company Information
- 8.7.2 Kedrion Biopharma Business Overview
- 8.7.3 Kedrion Biopharma Plasma Volume Expanders (PVEs) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Kedrion Biopharma Plasma Volume Expanders (PVEs) Product Portfolio
- 8.7.5 Kedrion Biopharma Recent Developments
- 8.8 IBM Micromedex
- 8.8.1 IBM Micromedex Company Information
- 8.8.2 IBM Micromedex Business Overview
- 8.8.3 IBM Micromedex Plasma Volume Expanders (PVEs) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 IBM Micromedex Plasma Volume Expanders (PVEs) Product Portfolio
- 8.8.5 IBM Micromedex Recent Developments
- 8.9 Grifols
- 8.9.1 Grifols Company Information
- 8.9.2 Grifols Business Overview
- 8.9.3 Grifols Plasma Volume Expanders (PVEs) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Grifols Plasma Volume Expanders (PVEs) Product Portfolio
- 8.9.5 Grifols Recent Developments
- 8.10 Fresenius Kabi
- 8.10.1 Fresenius Kabi Company Information
- 8.10.2 Fresenius Kabi Business Overview
- 8.10.3 Fresenius Kabi Plasma Volume Expanders (PVEs) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Fresenius Kabi Plasma Volume Expanders (PVEs) Product Portfolio
- 8.10.5 Fresenius Kabi Recent Developments
- 8.11 CSL Behring
- 8.11.1 CSL Behring Company Information
- 8.11.2 CSL Behring Business Overview
- 8.11.3 CSL Behring Plasma Volume Expanders (PVEs) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 CSL Behring Plasma Volume Expanders (PVEs) Product Portfolio
- 8.11.5 CSL Behring Recent Developments
- 8.12 Bio Products Laboratory Limited(Albuminex)
- 8.12.1 Bio Products Laboratory Limited(Albuminex) Company Information
- 8.12.2 Bio Products Laboratory Limited(Albuminex) Business Overview
- 8.12.3 Bio Products Laboratory Limited(Albuminex) Plasma Volume Expanders (PVEs) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Bio Products Laboratory Limited(Albuminex) Plasma Volume Expanders (PVEs) Product Portfolio
- 8.12.5 Bio Products Laboratory Limited(Albuminex) Recent Developments
- 8.13 B. Braun Medical, Inc
- 8.13.1 B. Braun Medical, Inc Company Information
- 8.13.2 B. Braun Medical, Inc Business Overview
- 8.13.3 B. Braun Medical, Inc Plasma Volume Expanders (PVEs) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 B. Braun Medical, Inc Plasma Volume Expanders (PVEs) Product Portfolio
- 8.13.5 B. Braun Medical, Inc Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Plasma Volume Expanders (PVEs) Value Chain Analysis
- 9.1.1 Plasma Volume Expanders (PVEs) Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Plasma Volume Expanders (PVEs) Production Mode & Process
- 9.2 Plasma Volume Expanders (PVEs) Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Plasma Volume Expanders (PVEs) Distributors
- 9.2.3 Plasma Volume Expanders (PVEs) Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst